Conlin O'Neil

Title: Conlin O'Neil: Innovator in Synthetic Nanocarrier Technology

Introduction

Conlin O'Neil is a notable inventor based in Andover, MA (US). He has made significant contributions to the field of immunology through his innovative work on synthetic nanocarriers. His research focuses on generating immune responses that can be crucial for therapeutic applications.

Latest Patents

O'Neil holds a patent titled "Methods for administering synthetic nanocarriers that generate humoral and cytotoxic T lymphocyte responses." This patent discloses methods for generating humoral and cytotoxic T lymphocyte (CTL) immune responses in a subject, along with related compositions. His work in this area has the potential to advance treatments for various diseases.

Career Highlights

Conlin O'Neil is currently employed at Selecta Biosciences, Inc., where he continues to develop innovative solutions in the field of biotechnology. His expertise in synthetic nanocarrier technology positions him as a key player in advancing medical research and applications.

Collaborations

O'Neil collaborates with esteemed colleagues, including David H Altreuter and Petr Ilyinskii. These partnerships enhance the research and development efforts at Selecta Biosciences, Inc., fostering a collaborative environment for innovation.

Conclusion

Conlin O'Neil's contributions to synthetic nanocarrier technology and his patent on immune response generation highlight his role as an influential inventor in the biotechnology sector. His work promises to pave the way for new therapeutic strategies in immunology.